| (USD) | Feb 2024 | Q/Q |
|---|---|---|
| Revenue | 37.1B | +1% |
| Gross Profit | 7B | +4% |
| Cost Of Revenue | 30B | +0% |
| Operating Income | -13.2B | - |
| Operating Expenses | 20.2B | - |
| Net Income | -5.9B | - |
| G&A | 7.9B | +16% |
| Amortization | 239MM | -0% |
| Interest Expense | 138MM | +39% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Under the deal, Walgreens will find candidates who are overweight or have obesity or diabetes and connect them with a Phase III clinical trial for Boehringer’s GLP-1 drug survodutide.
Boehringer is collaborating with EmVenio Research to introduce mobile community research units to extend the reach of trials.
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $17.53, indicating a +1.1% shift from the previous trading day.
Joint collaborations bring Boehringer Ingelheim's Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio's mobile research units, aimed at improving access to trials Originally published by Walgreens ...
Walgreens is ramping up its clinical trial offerings with Big Pharma players.
Walgreens’ decision to slash VillageMD’s clinical footprint has reverberated to the financial accounts of the primary care chain’s minority owner — Cigna.
Walgreens Boots Alliance Inc. (NASDAQ:WBA) is facing tumultuous times as it grapples with a challenging turnaround, leading to a drastic decline in its stock value, marking its worst performance in over five years. The company’s shares plummeted by 18% in April, nearing a 26-year low, following a downward revision of its outlook. This revision was accompanied by concerns over decreased consumer spending and the revelation of a substantial unpaid tax liability amounting to $2.7 billion, adding to
Walgreens, Lumen, Truist and Verizon are among the companies with the largest impairments in the past year.
Q1 2024 Franklin BSP Realty Trust Inc Earnings Call
Walmart announced it is closing down its healthcare business Tuesday. The move will impact 51 locations in five states, as well as relationships with health systems, like the one penned with Florida's Orlando Health in November.